Aurinia Pharmaceuticals Inc (AUPH) — Cash Flow Reinvestment Rate
Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Reinvestment Rate of 0.56x as of March 2026, reinvesting $18.08 Million (capex $39.00K plus investments $-18.04 Million) from operating cash flow of $32.56 Million. Check AUPH operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aurinia Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Aurinia Pharmaceuticals Inc across 2 annual periods. Explore long-term investment intensity of Aurinia Pharmaceuticals Inc to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Aurinia Pharmaceuticals Inc (2024–2025)
Year-by-year capital reinvestment analysis for Aurinia Pharmaceuticals Inc. For live market cap and broader valuation context, see Aurinia Pharmaceuticals Inc (AUPH) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | $32.77 Million | $135.66 Million | $252.00K | ▼ -72.9% |
| 2024 | 0.89x | $39.54 Million | $44.39 Million | $281.00K | — |